phleomycins has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, P; Jackson, SP | 1 |
| TANAKA, N; UMEZAWA, H; YAMAGUCHI, H | 1 |
| TANAKA, N | 1 |
3 other study(ies) available for phleomycins and Neoplasms
| Article | Year |
|---|---|
G9a inhibition potentiates the anti-tumour activity of DNA double-strand break inducing agents by impairing DNA repair independent of p53 status.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; DNA Breaks, Double-Stranded; DNA End-Joining Repair; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; HCT116 Cells; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Neoplasms; Phleomycins; Quinazolines; RNA Interference; Signal Transduction; Time Factors; Topoisomerase II Inhibitors; Transfection; Tumor Suppressor Protein p53 | 2016 |
Mechanism of action of phleomycin, a tumor-inhibitory antibiotic.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antineoplastic Agents; DNA; Escherichia coli; Neoplasms; Phleomycins; RNA | 1963 |
EFFECT OF PHLEOMYCIN ON DNA POLYMERASE OF TUMOR ORIGIN.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma 256, Walker; DNA-Directed DNA Polymerase; Mitomycin; Mitomycins; Neoplasms; Nucleotidyltransferases; Pharmacology; Phleomycins; Research | 1965 |